Related Experiment Video
Updated: Feb 22, 2026
07:01
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
926
Delirium in Pediatric Critical Care
Anita K Patel1, Michael J Bell2, Chani Traube3
1Pediatrics, Children's National Medical Center, 111 Michigan Avenue Northwest Suite M4800, Washington, DC 20010, USA.
Pediatric Clinics of North America
|September 25, 2017
Summary
Pediatric delirium, a brain dysfunction in critically ill children, is common and linked to worse outcomes. Early detection and intervention by pediatric intensivists can improve care and prevent complications.
Area of Science:
- Critical Care Medicine
- Pediatric Neurology
- Neuroscience
Background:
- Delirium is a frequent complication in critically ill children, characterized by acute onset and fluctuating cognitive disturbances.
- It signifies global cerebral dysfunction stemming from medical conditions or treatments in pediatric patients.
- Pediatric delirium is associated with adverse outcomes, including higher mortality and extended intensive care unit stays.
Purpose of the Study:
- To highlight the significance of delirium in critically ill children.
- To underscore the association between pediatric delirium and poor patient outcomes.
- To emphasize the role of pediatric intensivists in managing delirium.
Main Methods:
- This study is a review of existing literature and clinical observations regarding pediatric delirium.
- It focuses on the clinical presentation, underlying pathophysiology, and associated outcomes of delirium in pediatric intensive care.
- The review emphasizes the importance of clinical awareness and intervention strategies.
Main Results:
- Pediatric delirium is prevalent in the critically ill population.
- It is linked to increased mortality, prolonged mechanical ventilation, and extended intensive care unit length of stay.
- Delirium contributes to increased healthcare costs.
Conclusions:
- Heightened awareness allows pediatric intensivists to detect, treat, and prevent delirium in at-risk children.
- Effective management of pediatric delirium is crucial for improving patient outcomes.
- Early recognition and intervention can mitigate the negative consequences of delirium in pediatric critical care.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
302
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302
01:29Drug Dosing: Infants and Children
371
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
371
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
276
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
356
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
356
01:18Nightmares and Night Terrors
618
Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
Nightmares...
618
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
353
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
353